Modulation of fas/fasL in a murine retroviral infection by AZT and methionine enkephalin.
Bowden
R
R
University of South Florida College of Medicine, Department of Medical Microbiology & Immunology, Tampa 33612, USA.
Soto
S
S
Specter
S
S
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D004359:Drug Therapy, Combination; D004744:Enkephalin, Methionine / Q000008:administration & dosage / Q000494:pharmacology*; D053222:Fas Ligand Protein; D005260:Female; D005622:Friend murine leukemia virus; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D008562:Membrane Glycoproteins / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D012192:Retroviridae Infections / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D014412:Tumor Virus Infections / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D015215:Zidovudine / Q000008:administration & dosage / Q000494:pharmacology*; D019014:fas Receptor / Q000378:metabolism*
D000998:Antiviral Agents; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D008562:Membrane Glycoproteins; D019014:fas Receptor; D015215:Zidovudine; D004744:Enkephalin, Methionine